A Computationally Designed Water-Soluble Variant of a G-Protein-Coupled Receptor: The Human Mu Opioid Receptor
暂无分享,去创建一个
Jeffery G. Saven | Jin Xi | Renyu Liu | B. Selling | J. M. Perez-Aguilar | J. Saven | Renyu Liu | Jose Manuel Perez-Aguilar | Felipe Matsunaga | Xu Cui | Bernard Selling | J. Xi | Felipe Matsunaga | Xu Cui
[1] H. Attrill,et al. The role of cholesterol on the activity and stability of neurotensin receptor 1. , 2012, Biochimica et biophysica acta.
[2] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[3] H Kono,et al. Statistical Theory for Protein Combinatorial Libraries , 2001 .
[4] Pei Tang,et al. NMR studies of a channel protein without membranes: Structure and dynamics of water-solubilized KcsA , 2008, Proceedings of the National Academy of Sciences.
[5] C. K. Surratt,et al. Mutation of human μ opioid receptor extracellular “disulfide cysteine” residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane , 1999 .
[6] Vadim Cherezov,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[7] Yoko Shibata,et al. Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form , 2008, Proceedings of the National Academy of Sciences.
[8] U. Singh,et al. A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .
[9] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[10] Roland L. Dunbrack,et al. Bayesian statistical analysis of protein side‐chain rotamer preferences , 1997, Protein science : a publication of the Protein Society.
[11] Bryan L. Roth,et al. Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.
[12] R. MacKinnon,et al. Chemistry of ion coordination and hydration revealed by a K+ channel–Fab complex at 2.0 Å resolution , 2001, Nature.
[13] Arne Elofsson,et al. Why are polar residues within the membrane core evolutionary conserved? , 2011, Proteins.
[14] Werner Braun,et al. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules , 1998, J. Comput. Chem..
[15] C. Inturrisi. Clinical Pharmacology of Opioids for Pain , 2002, The Clinical journal of pain.
[16] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] J G Saven,et al. Statistical theory for protein combinatorial libraries. Packing interactions, backbone flexibility, and the sequence variability of a main-chain structure. , 2001, Journal of molecular biology.
[18] J. M. Perez-Aguilar,et al. Human μ Opioid Receptor Models with Evaluation of the Accuracy Using the Crystal Structure of the Murine μ Opioid Receptor , 2012, Journal of anesthesia & clinical research.
[19] Alessandro Senes,et al. Computational design of membrane proteins. , 2011, Current opinion in structural biology.
[20] A. Milon,et al. The N-Terminal End Truncated Mu-Opioid Receptor: from Expression to Circular Dichroism Analysis , 2010, Applied biochemistry and biotechnology.
[21] R. Stevens,et al. Recent progress in the structure determination of GPCRs, a membrane protein family with high potential as pharmaceutical targets. , 2010, Methods in molecular biology.
[22] D Eisenberg,et al. Hydrophobic organization of membrane proteins. , 1989, Science.
[23] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[24] B. Kieffer,et al. Expression of delta, kappa and mu human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins. , 1999, European journal of biochemistry.
[25] D. Ferguson,et al. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. , 2000, Journal of medicinal chemistry.
[26] R. Stevens,et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.
[27] Arne Elofsson,et al. Architecture of helix bundle membrane proteins: An analysis of cytochrome c oxidase from bovine mitochondria , 1997, Protein science : a publication of the Protein Society.
[28] B. Kuehn. Opioid Prescriptions Soar , 2007 .
[29] J G Saven,et al. Statistical theory of combinatorial libraries of folding proteins: energetic discrimination of a target structure. , 2000, Journal of molecular biology.
[30] One-Sun Lee,et al. Molecular Dynamics Simulation of WSK-3, a Computationally Designed, Water-Soluble Variant of the Integral Membrane Protein KcsA. , 2006, Biophysical journal.
[31] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[32] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[33] Bryan L. Roth,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[34] S. Boyault,et al. Overexpression and role of the ATPase and putative DNA helicase RuvB‐like 2 in human hepatocellular carcinoma , 2007, Hepatology.
[35] A. Milon,et al. The Full-Length Mu-Opioid Receptor: A Conformational Study by Circular Dichroism in Trifluoroethanol and Membrane-Mimetic Environments , 2008, Journal of Membrane Biology.
[36] Jack Snoeyink,et al. Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .
[37] Y. Fujiyoshi,et al. Structure and gating mechanism of the acetylcholine receptor pore , 2003, Nature.
[38] Christopher M. MacDermaid,et al. Theoretical and computational protein design. , 2011, Annual review of physical chemistry.
[39] Thijs Beuming,et al. A knowledge-based scale for the analysis and prediction of buried and exposed faces of transmembrane domain proteins , 2004, Bioinform..
[40] Mathias W. Hofmann,et al. An automated application for deconvolution of circular dichroism spectra of small peptides. , 2007, Analytical biochemistry.
[41] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[42] Peter B. McGarvey,et al. Infrastructure for the life sciences: design and implementation of the UniProt website , 2009, BMC Bioinformatics.
[43] Nora D Volkow,et al. Characteristics of opioid prescriptions in 2009. , 2011, JAMA.
[44] N. Tinel,et al. A Fluorescent Ligand-Binding Alternative Using Tag-lite® Technology , 2010, Journal of biomolecular screening.
[45] Jing He,et al. NMR structure and dynamics of a designed water-soluble transmembrane domain of nicotinic acetylcholine receptor. , 2012, Biochimica et biophysica acta.
[46] K. Gawrisch,et al. Bacterial expression of functional, biotinylated peripheral cannabinoid receptor CB2. , 2006, Protein expression and purification.
[47] Laxmaiah Manchikanti,et al. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. , 2008, Pain physician.
[48] P. Argos,et al. Knowledge‐based protein secondary structure assignment , 1995, Proteins.
[49] B. Monsarrat,et al. Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastoris. , 2005, Protein expression and purification.
[50] Jeffery G. Saven,et al. Computational design of water-soluble analogues of the potassium channel KcsA , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[51] Beyond the detergent effect: a binding site for sodium dodecyl sulfate (SDS) in mammalian apoferritin. , 2012, Acta crystallographica. Section D, Biological crystallography.
[52] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[53] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[54] Masao Nagasaki,et al. BFL: a node and edge betweenness based fast layout algorithm for large scale networks , 2009, BMC Bioinformatics.
[55] A Sali,et al. Comparative protein modeling by satisfaction of spatial restraints. , 1996, Molecular medicine today.
[56] Christopher K Surratt,et al. G protein-coupled receptor structural motifs: relevance to the opioid receptors. , 2005, Current topics in medicinal chemistry.
[57] B. Kuehn. Opioid prescriptions soar: increase in legitimate use as well as abuse. , 2007, JAMA.
[58] J. Slotte,et al. Cholesterol interactions with phospholipids in membranes. , 2002, Progress in lipid research.
[59] J. Changeux,et al. X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel , 2011, Nature.
[60] C. K. Surratt,et al. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane. , 1999, Brain research. Molecular brain research.
[61] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.